1. PROTAC Immunology/Inflammation NF-κB
  2. PROTACs STING NF-κB IKK
  3. PROTAC STING degrader-4

PROTAC STING degrader-4 是一种不含硝基的共价 STING PROTAC 降解剂,DC50 为 3.23 μM。PROTAC STING degrader-4 可有效抑制 STING 及其下游信号传导,例如 p-TBK1 和 p-NF-κB (p-P65) 以及免疫炎症细胞因子。PROTAC STING degrader-4 可减轻 Cisplatin (HY-17394) 诱发的急性肾损伤 (AKI) 小鼠模型中的肾脏和血液炎症。粉色:STING ligand (HY-176183);蓝色:CRBN ligase ligand (HY-103596);黑色:linker (HY-176182);CRBN ligase ligand + linker:HY-176181

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

PROTAC STING degrader-4 Chemical Structure

PROTAC STING degrader-4 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 PROTACs 亚型特异性产品:

查看 NF-κB 亚型特异性产品:

查看 IKK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PROTAC STING degrader-4 is a nitro-free covalent STING PROTAC degrader with a DC50 of 3.23 μM. PROTAC STING degrader-4 effectively inhibits STING as well as its downstream signaling, such as p-TBK1 and p-NF-κB (p-P65), and immune-inflammatory cytokines. PROTAC STING degrader-4 mitigates kidney and blood inflammation in Cisplatin (HY-17394)-induced acute kidney injury (AKI) mice model[1]. Pink: STING ligand (HY-176183); Blue: CRBN ligase ligand (HY-103596); Black: linker (HY-176182); CRBN ligase ligand + linker: HY-176181

IC50 & Target[1]

NF-κB

 

TBK1

 

体外研究
(In Vitro)

PROTAC STING degrader-4 (Compound 2h) (0.6-40 μM,2-72 小时) 以剂量和时间依赖性的方式降解 THP-1 dual 细胞中的 STING,持续 72 小时,其 DC50 为 3.23 μM (24小时)[1]
PROTAC STING degrader-4 (10 μM,48 小时) 通过蛋白酶体途径诱导 STING 降解[1]
PROTAC STING degrader-4 (0.3-20 μM,2 小时) 以剂量依赖性的方式降低 p-TBK1 和 p-NF-κB (p-P65) 的蛋白水平,从而抑制 STING 下游信号级联,而非直接降解 STING[1]
PROTAC STING degrader-4 (0.6-20 μM,2 小时) 显著且剂量依赖性地降低 IFN-β 和 CXCL10 的产生,并抑制 THP1-Dual 细胞中 IFNB1CXCL10ISG15mRNA 表达[1]
PROTAC STING degrader-4 (0.03-30 μM,24-48 小时) 在 THP1-Dual 和 RAW-Lucia 细胞 (低于 20 μM) 以及人类和小鼠正常细胞 (低于 30 μM) 中均表现出没有或弱细胞毒性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: THP-1 dual cells
Concentration: 0.6, 1.2, 2.5, 5, 10, 20, 40 μM
Incubation Time: 2, 4, 8, 12, 24, 48, 72 h
Result: Dose-dependently degraded STING with a DC50 of 3.23 μM (24 h) in THP-1 dual cells.
Continuously reduced the expression level of STING in THP1-dual cells for 72 h in THP-1 dual cells.
Induced potent degradation of STING, and this degradation effect was not inhibited by lysosome inhibitor BAF (Bafilomycin A1) (HY-100558) but was reversed by proteasome inhibitor MG132 (HY-13259) Induced the degradation of STING via the proteasome pathway rather than its warhead molecule or E3 ligase ligand, BAF (a lysosome inhibitor) and MG132 (a proteasome inhibitor).

Western Blot Analysis[1]

Cell Line: THP-1 dual cells
Concentration: 0.3, 0.6, 1.25, 2.5, 5, 10, 20 μM
Incubation Time: 2 h following MSA-2 (10 μM) for 16 h
Result: Dose-dependently reduced protein levels of p-TBK1 and p-NF-κB (p-p65), suppressing the STING downstream signaling cascade beyond direct degradation of STING.

Real Time qPCR[1]

Cell Line: THP-1 dual cells
Concentration: 0.6, 1.25, 2.5, 5, 10, 20 μM
Incubation Time: 2 h following MSA-2 (10 μM) for 24 h
Result: Significantly and dose-dependently inhibited IFNB1, CXCL10 and ISG15 mRNA expression in THP1-Dual cells.

Cell Viability Assay[1]

Cell Line: THP1-Dual, RAW-Lucia cells, human normal cell lines (HEK293T and WI38VA-13) and mouse normal cell lines (HT22 and MEF).
Concentration: 0.03, 0.07, 0.15, 0.31, 0.62, 1.25, 2.5, 5, 10, 20 μM (THP1-Dual and RAW-Lucia cells), 1.1, 3.3, 10, 30 μM (four human and mouse normal cell lines)
Incubation Time: 24, 48 h
Result: Did not exhibit significant inhibition of cellular viability below 20 μM in THP1-Dual and RAW-Lucia cells.
Exhibited no or weak cytotoxicity against four human and mouse cell lines at concentrations below 30 μM.
体内研究
(In Vivo)

PROTAC STING degrader-4 (Compound 2h) (30 mg/kg,腹腔注射,每日一次,持续 3 天) 通过降解 STING 和下游信号通路 (例如 p-IRF3) 显著缓解 Cisplatin 诱发的 AKI 小鼠模型中肾脏炎症[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male C57BL/6 mice (8 weeks old) were given Cisplatin administration (15 mg/kg) 1 h after PROTAC STING degrader-4 to induce AKI mice model[1].
Dosage: 30 mg/kg
Administration: i.p., daily for 3  days and then collected blood and kidney samples after cisplatin induction1.
Result: Potently mitigated ischemic symptoms of kidneys.
Significantly reduced the protein level of STING and p-IRF3 in kidney tissues.
Effectively reduced the mRNA levels of Tnfα, Isg15 and Cxcl10.
Effectively suppressed the production of CXCL10, IFN-β, IL-6 in plasma.
分子量

837.70

Formula

C39H42Cl2N8O9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PROTAC STING degrader-4
目录号:
HY-176180
需求量: